Skip to content

Intermediate Wheatgrass Products and Gut Health

The Effect of Regular Consumption of Intermediate Wheatgrass-Based Products on Measures of Gut Health

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07773441
Acronym
IWG Gut Health
Enrollment
54
Registered
2026-08-19
Start date
2024-09-01
Completion date
2026-08-31
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Fiber, Gastrointestinal Symptoms, Gut Health, Gut Microbiome

Keywords

Intermediate wheatgrass, Whole wheat, Gut health, Gastrointestinal symptoms, Gut Microbiome Wellness Index (GMWI), Gut microbiome

Brief summary

This study will evaluate the effect of daily consumption of intermediate wheatgrass-based products on measures of gut health compared with whole wheat-based products in healthy adults with traditional western fiber intake. Participants will first complete screening, stool sample collection, and the Diet History Questionnaire III. Participants with dietary fiber intake greater than 12g/1000 calories per day will complete the study after baseline procedures. Participants with dietary fiber intake of 12g/1000 calories per day or less will enter a randomized crossover dietary intervention. During the intervention, participants will consume intermediate wheatgrass-based products and whole wheat-based products in randomized order. Each intervention period will last 2 weeks and will be separated by a 2-week washout period. The primary outcome is change in Gut Microbiome Wellness Index. Gastrointestinal symptom scores will also be assessed.

Detailed description

Intermediate wheatgrass is a perennial grain that is high in protein, antioxidants, and fiber. This study is designed to evaluate whether regular consumption of intermediate wheatgrass-based products improves measures of gut health compared with whole wheat-based products in healthy adults consuming a traditional western fiber intake. The study will enroll healthy adults who are willing to consume bread products daily and have regular access to a smartphone. Participants will complete a REDCap pre-screening questionnaire. Eligible participants will complete informed consent, the National Cancer Institute Diet History Questionnaire III, and baseline stool sample collection. Participants with dietary fiber intake greater than 12g/1000 calories per day will complete participation after baseline procedures. Participants with dietary fiber intake of 12g/1000 calories per day or less will proceed to the randomized crossover dietary intervention. Participants in the crossover intervention will complete two 2-week dietary intervention periods separated by a 2-week washout period. They will be randomized to consume either intermediate wheatgrass-based products first or whole wheat-based products first. During each intervention period, participants will consume two slices of bread and 1/2 cup of puffed cereal per day. No additional dietary instruction will be provided. Gut health will be assessed using stool samples and the Gut Microbiome Wellness Index. Gastrointestinal symptoms and bowel movement patterns will be assessed using a modified Gastrointestinal Symptom Rating Scale questionnaire. Additional dietary intake information will be collected using diet recalls and a food logging smartphone application.

Interventions

DIETARY_SUPPLEMENTIntermediate Wheatgrass-Based Products

Participants will consume two slices of bread made from whole intermediate wheatgrass flour and 1/2 cup of puffed intermediate wheatgrass cereal per day for 2 weeks.

DIETARY_SUPPLEMENTWhole Wheat-Based Products

Participants will consume two slices of bread made from whole wheat flour and 1/2 cup of puffed whole wheat cereal per day for 2 weeks.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Intervention model description

Participants will be screened and enrolled as healthy individuals. After completing baseline stool collection and the Diet History Questionnaire III, participants with dietary fiber intake greater than 12g/1000 calories per day will complete participation. Participants with dietary fiber intake of 12g/1000 calories per day or less will proceed to the randomized crossover dietary intervention. These participants will complete both the intermediate wheatgrass-based product intervention and the whole wheat-based product intervention, separated by a 2-week washout period.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Greater than 18 years of age * Regular access to a smartphone * Willingness to consume bread products daily in accordance with study procedures

Exclusion criteria

* Antibiotic use within 3 months * Underlying chronic gastrointestinal disease, including irritable bowel syndrome, inflammatory bowel disease, and celiac disease * History of malabsorptive bariatric surgery or colectomy * Use of medications known to influence the gut microbiome * In the opinion of the investigator, unable to complete study procedures * Children * Pregnant women * Prisoners * Adults lacking capacity to consent or adults with diminished or fluctuating capacity to consent * Non-English speakers * Individuals unable to read

Design outcomes

Primary

MeasureTime frameDescription
Change in Gut Microbiome Wellness IndexBaseline through 6 weeksChange in Gut Microbiome Wellness Index will be assessed using stool sample-based microbiome analysis and compared after daily consumption of intermediate wheatgrass-based products versus whole wheat-based products.

Secondary

MeasureTime frameDescription
Change in Gastrointestinal Symptom ScoresBaseline through 6 weeksChange in gastrointestinal symptom scores will be assessed using a modified Gastrointestinal Symptom Rating Scale questionnaire during the study to compare gastrointestinal symptoms after intermediate wheatgrass-based product consumption and whole wheat-based product consumption.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLevi Teigen, PhD

University of Minnesota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026